Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Herantis Pharma Plc
Company release 9 June 2023 at 14:15 EEST
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Henri Huttunen
Position: Other senior manager
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 33227/4/4
____________________________________________
Transaction date: 2023-06-09
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2023 option rights in Herantis Pharma Plc
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 60000 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 60000 Volume weighted average price: 0 EUR ____________________________________________
Further information:
Julie Silber/Gabriela Urquilla
Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19
Email:ir@herantis.com
Certified Advisor: UB Securities Ltd, +358 9 25 380 225
Company website: www.herantis.com
Distribution:
Main media
www.herantis.com